Chesebro JH for the TIMI Investigators. Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, Heparin, and aspirin for acute myocardial infarction - Bovill, EG; Terrin, ML; Stump, DC; Berke, AD; Friderick, M; Collen, D; Feit, F; Gore, JM; Hillis, LD; Lambrew, CT; Leiboff, R; Mann, KG; Markis, JE; Pratt, CM; Sharkey, SW; Sopko, G; Tracy, RP (Annal Int Med, 1991)